Sara Belga, MD MPH
@sarabelga.bsky.social
Transplant ID physician in Vancouver with an interest in precision medicine, epidemiology/public health and all things CMV 🇨🇦🇵🇹
I’m from 🇨🇦 and not going.
August 13, 2025 at 4:07 AM
I’m from 🇨🇦 and not going.
Without having read it yet, this is screaming Strongy.
June 28, 2025 at 6:12 PM
Without having read it yet, this is screaming Strongy.
O rio é maravilhoso ❤️! Aproveitem 😊
June 3, 2025 at 12:22 AM
O rio é maravilhoso ❤️! Aproveitem 😊
The only work around for my health authority email has been to use Face ID to enter outlook.
January 28, 2025 at 4:28 AM
The only work around for my health authority email has been to use Face ID to enter outlook.
Yes, unfortunately. This paper quotes a risk of transmission in D+/R- livers of 20% which seems too high (versus <1% in kidneys) but need to prove check the actual reference.
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
Toxoplasmosis in organ transplant patients can be a result of donor-transmitted infection, or reactivation of latent infection, or de novo infection. Solid organ transplants including heart, liver, ki...
pmc.ncbi.nlm.nih.gov
January 15, 2025 at 4:39 AM
Yes, unfortunately. This paper quotes a risk of transmission in D+/R- livers of 20% which seems too high (versus <1% in kidneys) but need to prove check the actual reference.
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
To my knowledge limited data such as:
pubmed.ncbi.nlm.nih.gov/31769583/
academic.oup.com/cid/article-...
Seems relatively uncommon but potentially associated with high morbidity/mortality.
Since these patients need PJP prophylaxis in the 1st year with TMPSMX being preferred, why not proph them?
pubmed.ncbi.nlm.nih.gov/31769583/
academic.oup.com/cid/article-...
Seems relatively uncommon but potentially associated with high morbidity/mortality.
Since these patients need PJP prophylaxis in the 1st year with TMPSMX being preferred, why not proph them?
Toxoplasmosis in non-cardiac solid organ transplant recipients: A case series and review of literature - PubMed
The risk of toxoplasmosis in high-risk cardiac transplant recipients is well recognized prompting universal donor and candidate screening with administration of targeted post-transplant chemoprophylax...
pubmed.ncbi.nlm.nih.gov
January 14, 2025 at 7:13 PM
To my knowledge limited data such as:
pubmed.ncbi.nlm.nih.gov/31769583/
academic.oup.com/cid/article-...
Seems relatively uncommon but potentially associated with high morbidity/mortality.
Since these patients need PJP prophylaxis in the 1st year with TMPSMX being preferred, why not proph them?
pubmed.ncbi.nlm.nih.gov/31769583/
academic.oup.com/cid/article-...
Seems relatively uncommon but potentially associated with high morbidity/mortality.
Since these patients need PJP prophylaxis in the 1st year with TMPSMX being preferred, why not proph them?
Congrats Andrew!
December 30, 2024 at 7:36 PM
Congrats Andrew!
Hi Maricar, is this still open? The website says the application deadline has passed for volunteer sign up (Oct 31st).
November 18, 2024 at 2:18 AM
Hi Maricar, is this still open? The website says the application deadline has passed for volunteer sign up (Oct 31st).